KR Broder, MM Cortese, JK Iskander, K … - MMWR Recomm Rep, 2006 - cdc.gov During spring 2005, two tetanus toxoid, reduced diphtheria toxoid and acellular
pertussis vaccine (Tdap) products formulated for use in adolescents (and, for
one product, use in adults) were licensed in the United States (BOOSTRIX ® ... Cited by 98 - Related articles - Cached - All 5 versions
K Kretsinger, KR Broder, MM Cortese, MP … - MMWR Recomm Rep, 2006 - cdc.gov On June 10, 2005, a tetanus toxoid, reduced diphtheria toxoid and acellular
pertussis vaccine (Tdap) formulated for use in adults and adolescents was
licensed in the United States for persons aged 11--64 years (ADACEL ® , ... Cited by 87 - Related articles - Cached - All 4 versions
FB Pascual, EL McGinley, LR Zanardi, MM … - MORBIDITY AND MORTALITY WEEKLY REPORT …, 2003 - cdc.gov Results and Interpretation: During 1998--2000, an average of 43 cases of tetanus
was reported annually; the average annual incidence was 0.16 cases/million
population. The highest average annual incidence of reported tetanus was ... Cited by 80 - Related articles - Cached - BL Direct - All 4 versions
- ►jpedsurg.org DA Talan, FM Abrahamian, GJ Moran, WR … - Annals of emergency medicine, 2004 - Elsevier The seroprotection rate among 1,988 patients was 90.2% (95% confidence interval
88.8% to 91.5%). Groups with significantly lower seroprotection rates were
persons aged 70 years or older, 59.5% (risk ratio [RR] 5.2); immigrants ... Cited by 39 - Related articles - All 12 versions
P Van Damme, M Burgess - Vaccine, 2004 - Elsevier Two clinical studies were undertaken to evaluate the immunogenicity of an
adult-type dTpa booster vaccine (Boostrix™ by GlaxoSmithKline Biologicals).
Blood samples taken prior to vaccination showed that 24.4 and 13.0% of ... Cited by 24 - Related articles - All 6 versions
- ►ptolemy.ca [PDF] P Rhee, MK Nunley, D Demetriades, G … - The Journal of Trauma, 2005 - journals.lww.com Background: This review covers the pathogenesis and treatment of the disease
along with the reexamination of the current recommendations for prophylaxis
against tetanus in the United States. Although teta- nus is still a major ... Cited by 22 - Related articles - All 5 versions
- ►anesthanalg.net SM Wang, AA Caldwell-Andrews, ZN Kain - Anesthesia & Analgesia, 2003 - anesthanalg.net In a previous study, we indicated that 42% of surgical outpatients are
interested in using acupuncture as a treatment modality for preoperative
anxiety. We designed this follow-up survey to assess differences in ... Cited by 20 - Related articles - BL Direct - All 17 versions
TV Murphy, BA Slade, KR Broder, K Kretsinger … - MMWR Recommendations and Reports, 2008 - cdc.gov In 2005, two tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis
(Tdap) vaccines were licensed and recommended for use in adults and adolescents
in the United States: ADACEL ® (sanofi pasteur, Swiftwater, Pennsylvania), ... Cited by 18 - Related articles - Cached - All 3 versions
HF Gidding, JL Backhouse, MA Burgess, GL … - Medical Journal of Australia, 2005 - mja.com.au Population and study design National serosurveys are performed on behalf of the
National Centre for Immunisa- tion Research and Surveillance at the Centre for
Infectious Diseases and Microbiology using a bank of about 13000 residual ... Cited by 14 - Related articles - View as HTML - BL Direct - All 5 versions
HD Hüllstrung, D Mäusezahl, M Feuz, C … - Swiss Med Wkly, 2003 - smw.ch In industrialised countries tetanus has become a rare disease and cause of
death, mainly due to the implementation of broad immunisation pro- grammes. In
the US the yearly morbidity for tetanus fell from 3.7 to 0.15 per million ... Cited by 13 - Related articles - View as HTML - BL Direct - All 4 versions
